Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Protagonist Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PTGX.
You can purchase shares of Protagonist Therapeutics (NASDAQ:PTGX) through any online brokerage.
Other companies in Protagonist Therapeutics’s space includes: Immunovant (NASDAQ:IMVT), Avidity Biosciences (NASDAQ:RNA), Ultragenyx Pharmaceutical (NASDAQ:RARE), Ionis Pharmaceuticals (NASDAQ:IONS) and SpringWorks Therapeutics (NASDAQ:SWTX).
Protagonist Therapeutics has a consensus price target of $56.75.
The stock price for Protagonist Therapeutics (NASDAQ: PTGX) is $53.7972 last updated March 14, 2025 at 4:25 PM EDT.
There are no upcoming dividends for Protagonist Therapeutics.
Protagonist Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Protagonist Therapeutics.
Protagonist Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.